Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies

Diederik P Staal; Paul M Hendriks; Mitch C J van Thor; Liza D van de Groep; Leon M van den Toorn; Berend-Jan M Mulder; Prewesh P Chandoesing; Robert M Kauling; Sanne Boerman; Annemien E van den Bosch; Johannes J Mager; Karin A Boomars; Martijn C Post

doi:10.1002/pul2.12419

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies

Diederik P Staal^*
, Paul M Hendriks
, Mitch C J van Thor
, Liza D van de Groep
, Leon M van den Toorn
, Berend-Jan M Mulder
, Prewesh P Chandoesing
, Robert M Kauling
, Sanne Boerman
, Annemien E van den Bosch
, Johannes J Mager
, Karin A Boomars
, Martijn C Post

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

4 Downloads (Pure)

Abstract

Therapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH-specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; however, there was no difference in overall survival between the two cohorts.

Original language	English
Article number	e12419
Number of pages	6
Journal	Pulmonary Circulation
Volume	14
Issue number	3
DOIs	https://doi.org/10.1002/pul2.12419
Publication status	Published - Jul 2024

Keywords

chronic thromboembolic pulmonary hypertension
prognosis
pulmonary embolism
pulmonary hypertension
survival

Access to Document

10.1002/pul2.12419Licence: CC BY-NC

Pulm circ - 2024 - Staal - Inoperable chronic thromboembolic pulmonary hypertension Evolution of prognosis over 10 yearsFinal published version, 527 KBLicence: CC BY-NC

Cite this

Staal, D. P., Hendriks, P. M., van Thor, M. C. J., van de Groep, L. D., van den Toorn, L. M., Mulder, B.-J. M., Chandoesing, P. P., Kauling, R. M., Boerman, S., van den Bosch, A. E., Mager, J. J., Boomars, K. A., & Post, M. C. (2024). Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies. Pulmonary Circulation, 14(3), Article e12419. https://doi.org/10.1002/pul2.12419

@article{6617f92eeadc4dd4903a39d99362272e,

title = "Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies",

abstract = "Therapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH-specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; however, there was no difference in overall survival between the two cohorts.",

keywords = "chronic thromboembolic pulmonary hypertension, prognosis, pulmonary embolism, pulmonary hypertension, survival",

author = "Staal, \{Diederik P\} and Hendriks, \{Paul M\} and \{van Thor\}, \{Mitch C J\} and \{van de Groep\}, \{Liza D\} and \{van den Toorn\}, \{Leon M\} and Mulder, \{Berend-Jan M\} and Chandoesing, \{Prewesh P\} and Kauling, \{Robert M\} and Sanne Boerman and \{van den Bosch\}, \{Annemien E\} and Mager, \{Johannes J\} and Boomars, \{Karin A\} and Post, \{Martijn C\}",

note = "Publisher Copyright: {\textcopyright} 2024 The Author(s). Pulmonary Circulation published by Wiley Periodicals LLC on behalf of the Pulmonary Vascular Research Institute.",

year = "2024",

month = jul,

doi = "10.1002/pul2.12419",

language = "English",

volume = "14",

journal = "Pulmonary Circulation",

issn = "2045-8932",

publisher = "John Wiley \& Sons Inc.",

number = "3",

}

Staal, DP, Hendriks, PM, van Thor, MCJ, van de Groep, LD, van den Toorn, LM, Mulder, B-JM, Chandoesing, PP, Kauling, RM, Boerman, S, van den Bosch, AE, Mager, JJ, Boomars, KA & Post, MC 2024, 'Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies', Pulmonary Circulation, vol. 14, no. 3, e12419. https://doi.org/10.1002/pul2.12419

TY - JOUR

T1 - Inoperable chronic thromboembolic pulmonary hypertension

T2 - Evolution of prognosis over 10 years of new emerging therapies

AU - Staal, Diederik P

AU - Hendriks, Paul M

AU - van Thor, Mitch C J

AU - van de Groep, Liza D

AU - van den Toorn, Leon M

AU - Mulder, Berend-Jan M

AU - Chandoesing, Prewesh P

AU - Kauling, Robert M

AU - Boerman, Sanne

AU - van den Bosch, Annemien E

AU - Mager, Johannes J

AU - Boomars, Karin A

AU - Post, Martijn C

PY - 2024/7

Y1 - 2024/7

N2 - Therapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH-specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; however, there was no difference in overall survival between the two cohorts.

AB - Therapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH-specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; however, there was no difference in overall survival between the two cohorts.

KW - chronic thromboembolic pulmonary hypertension

KW - prognosis

KW - pulmonary embolism

KW - pulmonary hypertension

KW - survival

UR - https://www.scopus.com/pages/publications/85201663847

U2 - 10.1002/pul2.12419

DO - 10.1002/pul2.12419

M3 - Letter

C2 - 39175520

SN - 2045-8932

VL - 14

JO - Pulmonary Circulation

JF - Pulmonary Circulation

IS - 3

M1 - e12419

ER -

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this